Effect of vitamin D on insulin resistance in type 2 diabetic patients

Phase 3

• Conditions: Diabetes mellitus.; Diabetes mellitus; E10, E11,

• Registration Number: IRCT1138901221414N12
• Lead Sponsor: Endocrinology & Metabolism Research Center of Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1- Good control HbA1C (< 7.5%)
2- Treatment with oral hypoglycemic agents

Exclusion criteria:
1- Gross vitamin D deficiency
2- Renal failure, uncontrolled diabetes
3- Using daily multivitamine
4- Using oral vitamin D (one month prior to the study) or intravenous vit D in the 6 month period before the study
5- Uncontrolled hypertension

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin resistance. Timepoint: 90 days. Method of measurement: Blood sample & measurement of fasting blood sugar and insulin in formula hemostasis model assessment index( fasting insulin based on microinternational unit per mililiter * fasting blood sugar based on miligram per desiliter / 405).

Secondary Outcome Measures

Name	Time	Method
Glycemic status. Timepoint: 90 days. Method of measurement: Blood sample.